Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Licofor Plus is an ophthalmic nutraceutical and dietary supplement developed and manufactured by Farmigea (and marketed in partnership with Polifarma). It is formulated as a softgel capsule containing a synergistic combination of lycopene (Lyc-O-Mato), melatonin, and Reishi mushroom (*Ganoderma lucidum*) extract, alongside lutein, zeaxanthin, zinc, and a comprehensive complex of vitamins (B1, B2, B6, B12, D, and folic acid). The supplement is designed to support retinal health, protect ocular cells from oxidative stress, and maintain normal visual function. It is widely utilized as a supportive dietary intervention for patients with degenerative ocular conditions such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Licofor Plus.